Last reviewed · How we verify

NCT07229352

Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses

Not yet recruiting NA Last updated 26 December 2025
What this trial tests

NA trial testing Novel spectacle lens design in Myopia in 20 participants. Not yet recruiting.

Timeline
31 January 2026
Primary endpoint
31 March 2026
1 July 2026

Quick facts

Lead sponsorSightGlass Vision, Inc.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment20
Start date31 January 2026
Primary completion31 March 2026
Estimated completion1 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

SightGlass Vision, Inc.

Who can join

Adults 6 to 12, any sex, with Myopia or Myopia Progression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is evaluate and compare the mobility performance of children in daily activities while wearing single vision spectacle lenses (control) versus myopia control spectacle lenses (test).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Novel spectacle lens design

Trials testing the same drug.

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other SightGlass Vision, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07229352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing